Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin

Title
Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin
Authors
Keywords
COVID-19, G6PD, Oxidative stress, Polydatin
Journal
Clinical Nutrition ESPEN
Volume 43, Issue -, Pages 197-199
Publisher
Elsevier BV
Online
2021-03-19
DOI
10.1016/j.clnesp.2021.02.021

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started